EGFR and neoplasm: To assess the distribution of anti-EGFR nanobody D10 through the tumour tissue, a small high EGFR expressing A431 tumour with a volume of 6.6 mm3 was investigated by single plane illumination microscopy (SPIM) 45 min after intravenous administration of anti-EGFR nanobody AF488-D10.